77 related articles for article (PubMed ID: 23891184)
21. Antibacterial activity of chalcones, hydrazones and oxadiazoles against methicillin-resistant Staphylococcus aureus.
Moreira Osório T; Delle Monache F; Domeneghini Chiaradia L; Mascarello A; Regina Stumpf T; Roberto Zanetti C; Bardini Silveira D; Regina Monte Barardi C; de Fatima Albino Smânia E; Viancelli A; Ariel Totaro Garcia L; Augusto Yunes R; José Nunes R; Smânia A
Bioorg Med Chem Lett; 2012 Jan; 22(1):225-30. PubMed ID: 22169259
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
[TBL] [Abstract][Full Text] [Related]
23. Alternative therapies in Staphylococcus aureus diseases.
Kurlenda J; Grinholc M
Acta Biochim Pol; 2012; 59(2):171-84. PubMed ID: 22577619
[TBL] [Abstract][Full Text] [Related]
24. Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.
Lin MC; Hui CF; Chen JY; Wu JL
Peptides; 2013 Jun; 44():139-48. PubMed ID: 23598079
[TBL] [Abstract][Full Text] [Related]
25. Minimum inhibitory concentration and postantibiotic effect of amikacin for equine isolates of methicillin-resistant Staphylococcus aureus in vitro.
Caron JP; Bolin CA; Hauptman JG; Johnston KA
Vet Surg; 2009 Jul; 38(5):664-9. PubMed ID: 19573072
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and potent in vitro activity of novel 1H-benzimidazoles as anti-MRSA agents.
Karataş H; Alp M; Yildiz S; Göker H
Chem Biol Drug Des; 2012 Aug; 80(2):237-44. PubMed ID: 22497759
[TBL] [Abstract][Full Text] [Related]
27. Absolute Configuration and Conformational Study of Psammaplysins A and B from the Balinese Marine Sponge Aplysinella strongylata.
Mándi A; Mudianta IW; Kurtán T; Garson MJ
J Nat Prod; 2015 Aug; 78(8):2051-6. PubMed ID: 26237370
[TBL] [Abstract][Full Text] [Related]
28. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
Huang V; Cheung CM; Kaatz GW; Rybak MJ
Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792
[TBL] [Abstract][Full Text] [Related]
30. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
Desbois AP; Gemmell CG; Coote PJ
Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
[TBL] [Abstract][Full Text] [Related]
31. Anti-methicillin-resistant Staphylococcus aureus (MRSA) substance from the marine bacterium Pseudomonas sp. UJ-6.
Lee DS; Eom SH; Jeong SY; Shin HJ; Je JY; Lee EW; Chung YH; Kim YM; Kang CK; Lee MS
Environ Toxicol Pharmacol; 2013 Mar; 35(2):171-7. PubMed ID: 23434522
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of a Unique Psammaplysin F Library and Functional Evaluation in Prostate Cancer Cells by Multiparametric Quantitative Single Cell Imaging.
Kumar R; Bidgood CL; Levrier C; Gunter JH; Nelson CC; Sadowski MC; Davis RA
J Nat Prod; 2020 Aug; 83(8):2357-2366. PubMed ID: 32691595
[TBL] [Abstract][Full Text] [Related]
34. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.
Hsu DI; Hidayat LK; Quist R; Hindler J; Karlsson A; Yusof A; Wong-Beringer A
Int J Antimicrob Agents; 2008 Nov; 32(5):378-85. PubMed ID: 18701261
[TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibility patterns of methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus corneal isolates to antibiotics.
Elsahn AF; Yildiz EH; Jungkind DL; Abdalla YF; Erdurmus M; Cremona FA; Rapuano CJ; Hammersmith KM; Cohen EJ
Cornea; 2010 Oct; 29(10):1131-5. PubMed ID: 20595899
[TBL] [Abstract][Full Text] [Related]
36. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.
Hawser SP; Bouchillon SK; Hoban DJ; Dowzicky M; Babinchak T
Int J Antimicrob Agents; 2011 Mar; 37(3):219-24. PubMed ID: 21239146
[TBL] [Abstract][Full Text] [Related]
37. Focus: methicillin-resistant Staphylococus aureus (MRSA). Introduction.
Reygaert W
Clin Lab Sci; 2009; 22(2):109-10. PubMed ID: 19534444
[No Abstract] [Full Text] [Related]
38. Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin.
Jiang W; Li B; Zheng X; Liu X; Cen Y; Li J; Pan X; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2011 Aug; 11(8):1065-73. PubMed ID: 21396483
[TBL] [Abstract][Full Text] [Related]
39. Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin.
Marconescu P; Graviss EA; Musher DM
Scand J Infect Dis; 2012 Aug; 44(8):620-2. PubMed ID: 22668202
[TBL] [Abstract][Full Text] [Related]
40. Examination of a synthetic benzophenone membrane-targeted antibiotic.
Vooturi SK; Dewal MB; Firestine SM
Org Biomol Chem; 2011 Sep; 9(18):6367-72. PubMed ID: 21792399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
